Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Drugs and Therapeutics (D & T) Committee Meeting Results for: September 14, 2016

Drugs and Therapeutics (D & T) Committee

Meeting Results

September 14, 2016

Drug Name

Review Type

Committee Recommendation

Prior Approval Status – Final Determination

Viekira XR

New Drug Initial Review

Require Prior Approval (Non-Preferred)
Prior Approval Required (Non-Preferred)

Epclusa

New Drug Initial Review
Preferred with a Prior Approval
Preferred with a Prior Approval

Ocaliva

New Drug Initial Review

Require Prior Approval (Non-Preferred)
Prior Approval Required (Non-Preferred)

Briviact

New Drug Initial Review

Require Prior Approval (Non-Preferred)
Prior Approval Required (Non-Preferred)

Xtampza ER

New Drug Initial Review
Require Prior Approval (Non-Preferred)
Prior Approval Required (Non-Preferred)

Adzenys XR-ODT

New Drug Initial Review
Require Prior Approval (Non-Preferred)
Prior Approval Required (Non-Preferred)

Spinosad

New Drug Initial Review
Remove Prior Approval (Preferred)
Prior Approval Removed (Preferred)

Orenitram ER

New Drug Appeal
Require Prior Approval (Non-Preferred)
Prior Approval Required (Non-Preferred)